Superoxide dismutase, mitochondrial (SOD2)


UniProt Number: P04179
Alternate Names: Mn-SOD, Mn-SOD2, MnSOD, MnSOD2
Structure and Function: Aerobic organisms have several mechanisms to protect against oxidation, particularly from harmful reactive oxygen species (ROS). The principle cellular anti-oxidants are the superoxide dismutase family (SOD, E.C. 1.15.1.1). These enzymes dismutate superoxide into hydrogen peroxide which is further detoxified by other cellular defenses such as glutathione peroxidase and catalase. Superoxide and its products have been implicated in a wide range of diseases including cancer, inflammation, neurodegenerative diseases, diabetes and aging itself.

The SOD family has 3 members, two of which are Cu-Zn type - the extracellular SOD3 and the cytoplasmic SOD1. The other member is the mitochondrial Mn type SOD2.

The mitochondrial Mn-SOD2 is a homotetramer of subunit mass 23 kDa in the mitochondrial matrix. SOD2 has been shown to be essential since knockout mice die shortly after birth. SOD2 levels may be down-regulated in tumor cells and recent observations show that over expression of SOD2 in tumor cells may suppress cell division and cancer growth (Oberley, Biomedecine & Pharmacotherapy, 2005, 59, p143-8).
Disease Associations: Genetic variation in SOD2 is associated with susceptibility to diabetic nephropathy [MIM:612634]; also called susceptibility to microvascular complications of diabetes type 6 (MVCD6).


Monoclonal Antibodies
Cat. No. Name Reactivity Apps. Amount
MS732 SOD2 Antibody Human, Bovine, Rat, Mouse ICC, IHC, IP, ICE, FLOW 100 µg


Protein Quantity Assays
Cat. No. Name Reactivity Amount
ab119694 SOD2 Human ELISA Kit Human 96 Tests



Browse Products By:
Product Search:




Related Pathways:



Free Radical Scavenging


Subscribe to MitoNews
MitoNews is a free periodic annotated review of important publications in mitochondria and metabolic research.

MitoNews Latest Issue
Volume 11 Issue 01 (February 2015)

MitoNews Archives


Sales & Customer Support:
1-888-772-2226

[email protected]

© 2004-2022 MitoSciences Inc, an Abcam company. All rights reserved.